20 LATEST RESOURCES (291 INDEXED)
Hypothyroidism and Sinus Dysfunction Associated with Lithium-Paliperidone Combination Therapy for Bipolar Disorder with Psychotic Symptoms: A Case Report · February 2024
Articles
Frontiers in Psychiatry
Neutropenia in a Schizophrenia Patient Following Combined Lurasidone and Paliperidone Therapy: A Case Report · November 2023
Articles
Advances in Psychiatry and Neurology
Paliperidone Long-Acting Injection in the Treatment of an Adolescent with Schizophrenia with Fluctuating Mental Symptoms during Menstrual Period: A Case Report · October 2023
Articles
Frontiers in Psychiatry
Plasmatic Levels and Response to Variable Doses of Monthly Aripiprazole and Three-Month Paliperidone in Patients with Severe Schizophrenia: Treatment Adherence, Effectiveness, Tolerability, and Safety · October 2023
Articles
Neuropsychiatric Disease and Treatment
Cortical Thickness, Gray-White Matter Contrast, and Intracortical Myelin in First-Episode Schizophrenia Patients Treated with Long-Acting Paliperidone Palmitate versus Oral Antipsychotics · July 2023
Articles
Psychiatry Research
Effects of Risperidone/Paliperidone versus Placebo on Cognitive Functioning Over the First 6 Months of Treatment for Psychotic Disorder: Secondary Analysis of a Triple-Blind Randomised Clinical Trial · June 2023
Articles
Translational Psychiatry
Paliperidone-Induced Hypertriglyceridemia Resulting in Acute Interstitial Pancreatitis · April 2023
Articles
Primary Care Companion for CNS Disorders
Efficacy and Safety of Paliperidone Palmitate 6-Month versus Paliperidone Palmitate 3-Month Long-Acting Injectable in European Patients with Schizophrenia: A Post Hoc Analysis of a Global Phase-3 Double-Blind Randomized Non-Inferiority Study · April 2023
Articles
Neuropsychiatric Disease and Treatment
Tolerability Profile of Paliperidone Palmitate Formulations: A Pharmacovigilance Analysis of the EUDRAVigilance Database · April 2023
Articles
Frontiers in Psychiatry
Paliperidone Palmitate versus Risperidone Long-Acting Injectable in Patients with Schizophrenia: A Meta-Analysis of Efficacy and Safety · April 2023
Articles
Neuropsychiatric Disease and Treatment
Prospective, Randomized, Multicenter Clinical Trial Evaluating Longitudinal Changes in Brain Function and Microstructure in First-Episode Schizophrenia Patients Treated with Long-Acting Injectable Paliperidone Palmitate versus Oral Antipsychotics · April 2023
Articles
Schizophrenia Research
Paliperidone Palmitate: A Breakthrough Treatment for Schizophrenia? A Review on Patient Adherence Levels, Healthcare Resource Utilization and Costs · March 2023
Articles
Neuropsychiatric Disease and Treatment
Effects of Long-Acting Injectable 3-Monthly Paliperidone Palmitate on the Clinical and Social Performance of Patients with Schizophrenia · February 2023
Articles
Clinical Psychopharmacology and Neuroscience
Effectiveness of Paliperidone Palmitate in Reducing Acute Psychiatric Service Use for Patients Suffering from Psychosis-A Retrospective Mirror-Image Study · February 2023
Articles
International Journal of Environmental Research and Public Health
Paliperidone Palmitate vs. Paliperidone Extended-Release for the Acute Treatment of Adults with Schizophrenia: A Systematic Review and Pairwise and Network Meta-Analysis · December 2022
Articles
Translational Psychiatry
Paliperidone-Associated Sialorrhea: A Case Report with Review of Current Literature · September 2022
Abstracts
Journal of Clinical Psychopharmacology
Long-Acting Paliperidone in Ekbom’s Syndrome in Lewy Body Dementia: A Case Report · July 2022
Articles
Translational Neuroscience
Paliperidone Extended Release versus Olanzapine in Treatment-Resistant Schizophrenia: A Randomized, Double-Blind, Multicenter Study · July 2022
Abstracts
Journal of Clinical Psychopharmacology
Using Cariprazine to Ameliorate Negative Symptoms and Metabolic Side Effects of Clozapine and Paliperidone – Clinical Cases · June 2022
Articles
Neuropsychiatric Disease and Treatment